Multiple myeloma long-term survivors display sustained immune alterations decades after first line therapy
R. Lutz, F. Gruenschlaeger, M. Simon, M. Bauer, S. Yousefian, N. Beumer, L. Jopp-Saile, M. Awwad, G. Steinbuss, A. Sedlmeier, T. Boch, D. Vonficht, M.-A. Baertsch, B. Durie, N. Weinhold, , S. Haas
This study examines immune changes in multiple myeloma survivors years after treatment, finding sustained immune alterations linked to residual disease and therapy.
bioRxiv · May 27, 2023 · PreprintCancer Biology